FABP4 and hepatocellular carcinoma: As recently reported [27], we also confirmed in vitro the effect of FABP4 on HCC progression as cell proliferation and migration were increased by incubating hepatoma cell lines with eFABP4, both effects being reversed in the presence of a specific FABP4 inhibitor.